Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV

Active, not recruitingOBSERVATIONAL

Enrollment

2,800

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Hepatitis C Viral

Trial Locations (1)

NHS Tayside, Dundee

All Listed Sponsors

lead

University of Dundee

OTHER

NCT03356405 - Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV | Biotech Hunter | Biotech Hunter